0001179110-13-017667.txt : 20131210 0001179110-13-017667.hdr.sgml : 20131210 20131210161528 ACCESSION NUMBER: 0001179110-13-017667 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131206 FILED AS OF DATE: 20131210 DATE AS OF CHANGE: 20131210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CATLIN AVERY W CENTRAL INDEX KEY: 0001255348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 131268602 MAIL ADDRESS: STREET 1: 241 CENTRAL STREET CITY: HINGHAM STATE: MA ZIP: 02043 4 1 edgar.xml FORM 4 - X0306 4 2013-12-06 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001255348 CATLIN AVERY W C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE NEEDHAM MA 02494 0 1 0 0 Sr. VP & CFO Common Stock 2013-12-06 4 M 0 183333 8.16 A 197442 D Common Stock 2013-12-06 4 S 0 183333 24.50 D 14109 D Incentive Stock Option 8.16 2013-12-06 4 M 0 49016 0 D 2009-03-07 2015-03-07 Common Stock 49016 134317 D Non-Qualified Stock Option 8.16 2013-12-06 4 M 0 134317 0 D 2009-03-07 2015-03-07 Common Stock 134317 0 D The option vested in four equal annual installments on March 7, 2009, March 7, 2010, March 7, 2011 and March 7,2012. The option vested in four annual installments. 33,580 shares on March 7, 2009 and 33,579 shares on March 7, 2010, March 7, 2011 and March 7, 2012. /s/ Anthony S. Marucci, attorney in fact for Avery W. Catlin 2013-12-10